ArticleIndian journal of psychiatry2025
Telepsychiatry in addiction treatment: Evaluating India's telemedicine guidelines.
Article in Indian journal of psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Telemedicine has improved healthcare delivery by enhancing treatment access and convenience. India's telemedicine adoption was limited before COVID-19 due to legal ambiguity and judicial barriers, but the pandemic prompted the development and implementation of Telemedicine and Telepsychiatry Operational Guidelines. The telemedicine guideline established ethical frameworks, consultation protocols, and medication categories for tele-consultation. This viewpoint article examines the advantages and limitations of current telemedicine guidelines in the context of addiction treatment. Given India's high substance uses prevalence, rural healthcare disparities, and a huge substance use disorder treatment gap, telepsychiatry offers a path to improve treatment access and thereby, reducing stigma and improve treatment outcomes. Even though the current telemedicine guideline is a good first step, it is severely limiting addiction treatment. The major limitations are restrictive medication lists, lack of evidence-based recommendations, privacy concerns, and regulatory gaps. Key recommendations include reclassifying non-abusable medications and adequately addressing legal and privacy concerns.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.